Peginterferon α-2a Combination Therapies in Chronic Hepatitis C Patients Who Relapsed After or Had a Viral Breakthrough on Therapy with Standard Interferon α-2b Plus Ribavirin: A Pilot Study of Efficacy and Safety

By Herrine Steven   Brown Robert   Bernstein David   Ondovik Michael   Lentz Ellen   Te Helen  

Digestive Diseases and Sciences, Vol. 50, Iss. 4, 2005-04 ,pp. : 719-726

Springer Publishing Company

Access to resources Recommend Favorite

Retreatment with peg-interferon and ribavirin in patients with chronic hepatitis C virus genotype 2 or 3 infection with prior relapse

By Lagging Martin  

Scandinavian Journal of Gastroenterology, Vol. 48, Iss. 7, 2013-07 ,pp. : 839-847

Informa Healthcare

Access to resources Recommend Favorite

From Trials to a Real Hospital Setting: Effectiveness of Pegylated Interferon-α-2b/Ribavirin Combination Therapy for Naïve Chronic Hepatitis C Patients

By Piai Guido   Scalice Elisa   Focareta Rosaria   Terracciano Fulvia   Filippo Francesca   Forte Giovambattista  

Digestive Diseases and Sciences, Vol. 51, Iss. 9, 2006-09 ,pp. : 1619-1626

Springer Publishing Company

Access to resources Recommend Favorite

Sustained Virological Response after 8-Week Treatment of Simeprevir with Peginterferon α-2a plus Ribavirin in a Japanese Female with Hepatitis C Virus Genotype 1b and IL28B Minor Genotype

By  

Case Reports in Gastroenterology, Vol. 9, Iss. 2, 2015-07 ,pp. : 215-220

Karger

Access to resources Recommend Favorite

Response to Combination Therapy with Interferon Alfa-2a and Ribavirin in Chronic Hepatitis C According to a TNF-α Promoter Polymorphism

By  

Digestion, Vol. 68, Iss. 1, 2003-10 ,pp. : 1-4

Karger

Access to resources Recommend Favorite